Proqr Therapeutics N.V. (PRQR) SEC Filings — 2025
11 SEC filings for Proqr Therapeutics N.V. (PRQR) in 2025.
Filings
- ProQR Therapeutics Files 6-K Report — 6-K · Nov 6, 2025
- ProQR Therapeutics Advances AX-0810 Towards Clinic — 6-K · Nov 3, 2025
- ProQR Therapeutics Gets CTA Approval for AX-0810 — 6-K · Oct 20, 2025
- ProQR Therapeutics Files 6-K Report — 6-K · Aug 7, 2025
- ProQR Therapeutics Submits CTA for AX-0810 Phase 1 Study — 6-K · Jun 26, 2025
- ProQR Therapeutics Holds 2025 Annual Shareholder Meeting — 6-K · Jun 3, 2025
- ProQR Therapeutics Files 6-K for Q1 2025 — 6-K · May 8, 2025
- ProQR Therapeutics Sets Annual Shareholder Meeting for June 3 — 6-K · May 1, 2025
- ProQR Therapeutics Appoints New CFO and CMO — 6-K · Apr 14, 2025
- ProQR Therapeutics Files 6-K with Results Announcement — 6-K · Mar 13, 2025
- ProQR Therapeutics N.V. Files 2024 Annual Report — 20-F · Mar 13, 2025